Maryam Noroozian
Maryam Noroozian
Verified email at tums.ac.ir - Homepage
Title
Cited by
Cited by
Year
Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial
S Akhondzadeh, M Noroozian, M Mohammadi, S Ohadinia, AH Jamshidi, ...
Journal of clinical pharmacy and therapeutics 28 (1), 53-59, 2003
4702003
Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomised, placebo controlled trial
S Akhondzadeh, M Noroozian, M Mohammadi, S Ohadinia, AH Jamshidi, ...
Journal of Neurology, Neurosurgery & Psychiatry 74 (7), 863-866, 2003
4162003
The elderly population in iran: an ever growing concern in the health system
M Noroozian
Iranian journal of psychiatry and behavioral sciences 6 (2), 1, 2012
2352012
Parental reports on the efficacy of treatments and therapies for their children with autism spectrum disorders
RP Goin-Kochel, VH Mackintosh, BJ Myers
Research in Autism Spectrum Disorders 3 (2), 528-537, 2009
1772009
Psychiatric morbidity among sentenced prisoners: prevalence study in Iran
SM Assadi, M Noroozian, M Pakravannejad, O Yahyazadeh, S Aghayan, ...
The British Journal of Psychiatry 188 (2), 159-164, 2006
1472006
Validity of the Farsi version of mini-mental state examination
M Seyedian, M FALAH, M NOUROUZIAN, S NEJAT, A Delavar, ...
JOURNAL OF MEDICAL COUNCIL OF IRI 25 (4), 408-414, 2008
1182008
Detection of abnormalities for diagnosing of children with autism disorders using of quantitative electroencephalography analysis
A Sheikhani, H Behnam, MR Mohammadi, M Noroozian, M Mohammadi
Journal of medical systems 36 (2), 957-963, 2012
1102012
Prevalence of epilepsy and comorbidity of psychiatric disorders in Iran
MR Mohammadi, A Ghanizadeh, H Davidian, M Mohammadi, ...
Seizure 15 (7), 476-482, 2006
1092006
Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial
S Akhondzadeh, N Mohammadi, M Noroozian, N Karamghadiri, ...
Schizophrenia research 107 (2-3), 206-212, 2009
1052009
Caregiver burden and its determinants among the family members of patients with dementia in Iran
I Abdollahpour, M Noroozian, S Nedjat, R Majdzadeh
International journal of preventive medicine 3 (8), 544, 2012
862012
Brain complexity increases in mania
B Bahrami, R Seyedsadjadi, B Babadi, M Noroozian
Neuroreport 16 (2), 187-191, 2005
642005
Nitric oxide and peroxynitrite serum levels in Parkinson’s disease: correlation of oxidative stress and the severity of the disease
L Kouti, M Noroozian, S Akhondzadeh, M Abdollahi, MR Javadi, ...
Eur Rev Med Pharmacol Sci 17 (7), 964-970, 2013
602013
A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia
S Akhondzadeh, M Gerami, M Noroozian, N Karamghadiri, A Ghoreishi, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (8), 1810-1815, 2008
572008
Caregiver burden: the strongest predictor of self-rated health in caregivers of patients with dementia
I Abdollahpour, S Nedjat, M Noroozian, Y Salimi, R Majdzadeh
Journal of geriatric psychiatry and neurology 27 (3), 172-180, 2014
532014
The role of the cerebellum in cognition: beyond coordination in the central nervous system
M Noroozian
Neurologic clinics 32 (4), 1081-1104, 2014
472014
Mesenchymal stem cells as an alternative for Schwann cells in rat spinal cord injury
A Zaminy, MA Shokrgozar, Y Sadeghi, M Noroozian, MH Heidari, ...
Iranian biomedical journal 17 (3), 113, 2013
462013
Psychopathy in Iran: A cross-cultural study
SV Shariat, SM Assadi, M Noroozian, M Pakravannejad, O Yahyazadeh, ...
Journal of personality disorders 24 (5), 676-691, 2010
462010
A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia
M Noroozian, S Ghasemi, SMR Hosseini, A Modabbernia, ...
Psychopharmacology 228 (4), 595-602, 2013
392013
Alzheimer's disease: pathophysiology and pharmacotherapy.
S Akhondzadeh, M Noroozian
IDrugs: the investigational drugs journal 5 (11), 1062-1069, 2002
382002
Which variable is the strongest adjusted predictor of quality of life in caregivers of patients with dementia?
I Abdollahpour, S Nedjat, Y Salimi, M Noroozian, R Majdzadeh
Psychogeriatrics 15 (1), 51-57, 2015
372015
The system can't perform the operation now. Try again later.
Articles 1–20